Migraine sufferers anxiously await the day when a pill will suddenly make the pain and other symptoms cease. Unfortunately, even the latest in medication doesn’t seem to promise those results. One new drug called galcanezumab was tested on chronic migraines sufferers. You might be surprised to learn what the pharmaceutical industry considers a successful study.
Lackluster Results for New Migraine Drug in Experimental Test
The test consisted of chronic migraine patients who averaged 19.7 episodes per month. Patients took the drug in two doses, with the lower dose performing the better of the two. This dose, 120 mg, resulted in 4.8 fewer episodes for patients, decreasing the average to 14.9 days per month. With the number dropped to below 15 days per month, a person is no longer having chronic migraines.
As a result, this medication could be the next treatment for chronic migraines and analysts expect sales to reach close to half a billion US dollars by 2022. Here are two problems with the results.
- The placebo group saw a reduction in migraines by 2.7 days per month, so the pill only provided a 2.1-day advantage over a fake pill.
- Patients were still experiencing an average of 14.9 migraine days per month after treatment. Improvement? Sure. But not worth hundreds of millions of dollars.
A Natural Way to Help
Upper cervical chiropractic offers a far less expensive way to approach chronic migraines. A misalignment of the atlas (C1) or axis (C2) is often an underlying cause of this neurological condition. If such a misalignment is restricting blood and cerebrospinal fluid flow or affecting brainstem function, migraines can result. A gentle and precise correction has helped many to find relief. Some see fewer and less severe episodes, while others may attain total relief. To learn more about this natural approach to get relief, contact an upper cervical practice near you.